Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03998046
Other study ID # STU00207153
Secondary ID R34DK114773
Status Completed
Phase N/A
First received
Last updated
Start date December 16, 2019
Est. completion date June 30, 2021

Study information

Verified date January 2022
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The C3PO pilot and feasibility study uses a rigorous, mixed-method research design to provide information needed to refine and implement a technology-mediated primary care outreach intervention approach before conducting a larger and more definitive future intervention trial.


Description:

This study will implement and evaluate a pragmatic and generalizable framework for population management of obesity by the primary care sector. With patient and other stakeholder input, the C3PO intervention will be designed to leverage existing primary care professionals and technologies to implement a scalable framework for population obesity management that coordinates primary care services with extant intensive lifestyle interventions in community settings to achieve wider reach and population-level effectiveness. A rigorous, mixed-method pilot and feasibility study will provide critical information needed to optimize the intervention design and prepare us for a larger and definitive future trial.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date June 30, 2021
Est. primary completion date June 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - BMI = 27 kg/m2 - = 1 CVD risk condition (hypertension, dyslipidemia, prediabetes or type 2 diabetes) - Registered in Northwestern Medical Group's EpicCare MyChart patient portal - Received and completed MyChart survey of weight loss interest - Affirms interest in weight loss goal setting and receiving additional resource information and electronic Scale. Exclusion Criteria: - Evidence of hospitalization in past 30 days - Most recent blood pressure >180/105 - Cancer (non-skin) treatment within the past 2 years - Encounter diagnosis for hypoglycemia in past 30 days - Actively receiving care from the bariatric surgery service or a bariatric medication order in the past 100 days

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Outreach Support for Weight Loss Goal Setting and Self-Weighing
Patients will receive a MyChart activation message assessing weight loss interest that invites them to complete a MyChart Survey encouraging a weight loss goal using principles adapted from Brief Action Planning. Patients will then receive a cellular network-enabled electronic body weight scale, and weighing data transmitted by the scale will be received and integrated into the electronic health record for access by the patient's primary care team.
Outreach Decision Support to Encourage Linkages to Intensive Community Lifestyle Interventions
Patients will receive via MyChart information and decision support designed to encourage linkages to and participation in intensive lifestyle programs available in the community. Patients who request information or clinical referrals will also receive them. "Refreshes" of community linkage information will be sent by MyChart every 1 to 4 weeks.
Adaptive Tailoring of Information Delivery and Intensity of Primary Care Outreach Support
Data received into the electronic health record from the cellular network-enabled electronic scale will categorize each patient based on their daily self-weighing behaviors and rate of progress towards their weight loss goal. Patients who are not engaged in daily self-weighing or are not making progress towards their goal will receive more intensive outreach support in the form of automated weekly MyChart problem solving messages, more frequent encouragement to access a broader array of community resources, and telephonic support from a nurse care coordinator who is an existing member of the primary care team. Support from this nurse care coordinator will be facilitated by the incorporation of each patient's self-weighing data into an EpicCare patient dashboard accessible to the nurse coordinator and other members of the care team

Locations

Country Name City State
United States Northwestern Medicine Chicago Illinois

Sponsors (2)

Lead Sponsor Collaborator
Northwestern University National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants Who Achieved 5% Weight Loss Goal at 6 Months Proportion of Participants who Reach a 5% Weight Loss Goal at 6 Months, calculated as the percent of all participants for whom the following calculation is greater than or equal to 5%: (Baseline body mass (kg) - Body mass measured at 6 months (kg))/(Baseline body mass (kg)) Baseline - 6 Months
Secondary Costs to Implement the Intervention Costs (US$) of Intervention Components, including the costs to fund personnel efforts, technology, and other intervention components Baseline - 12 Months
Secondary Change in Hemoglobin A1C Mean change in Hemoglobin A1C levels (DCCT%) from baseline to 12 months Baseline - 12 Months
Secondary Change in Systolic Blood Pressure Mean change in systolic blood pressure (mmHg) from baseline to 12 months Baseline - 12 Months
Secondary Change in Total Cholesterol Mean change in total cholesterol concentration (mg/dL) from baseline to 12 months Baseline - 12 Months
Secondary Change in Non-HDL Cholesterol Mean change in non-HDL cholesterol concentration (mg/dL) from baseline to 12 months Baseline - 12 Months
Secondary Body Mass Change at 6 Months Mean Change in Body Mass (kg) from Baseline to 6 Months Baseline - 6 Months
Secondary Body Mass Change at 12 Months Mean Change in Body Mass (kg) from Baseline to 12 Months Baseline - 12 Months
Secondary Number of Participants Who Achieved 5% Weight Loss Goal in 12 Months Proportion of Participants who Reach a 5% Weight Loss Goal at 12 Months, calculated as the percent of all participants for whom the following calculation is greater than or equal to 5%: (Baseline body mass (kg) - Body mass measured at 12 months (kg))/(Baseline body mass (kg)) Baseline - 12 Months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2